IRMD | IRadimed Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	48.31 - 50.00
52 Week Range	36.12 - 50.93
Beta	1.10
Implied Volatility	11.46%
IV Rank	68.22%
Day's Volume	45,858
Average Volume	53,162
Shares Outstanding	12,669,800
Market Cap	613,851,810
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2014-07-16

Valuation
Profitability
Growth
Health
P/E Ratio	33.18
Forward P/E Ratio	29.90
EPS	1.46
1YR Price Target	42.00
Dividend Yield	1.24%
Dividend Per Share	0.60
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	148
Country	USA
Website	IRMD

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally.

IRMD's peers: AXDX, ELMD, DCTH, FNA, GKOS, HYPR, LUNG, OFIX, NPCE, ITGR, HSKA, CNMD, OSA, LIVN, KIDS, SRDX, SGHT, ANIK, LUCD, MXCT, NVRO, PROF, RCEL, RXST, SIBN, TMCI, UFPT, VREX

*Chart delayed

Analyzing fundamentals for IRMD we got that it has strong fundamentals where Valuation is considered to be overvalued, Profitability is stunning wealthy, Growth is exceptionally good and Health is confidently strong. For more detailed analysis please see IRMD Fundamentals page.

Watching at IRMD technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on IRMD Technicals page.